TSX Venture Exchange, Satellos Bioscience Inc., View From The C-Suite
2023年8月22日 - 3:51AM
PR Newswire (Canada)
TORONTO, Aug. 21,
2023 /CNW/ - Frank Gleeson, Chief Executive
Officer, Satellos Bioscine (TSXV: MSCL) ("Satellos" or the
"Company") shares his Company's story in
an interview with TMX Group.
The View From The C-Suite video interview series highlights the
unique perspectives of listed companies on Toronto Stock Exchange
and TSX Venture Exchange. Videos provide insight into how
company executives think in the current business
environment. To see the latest View From The C-Suite visit
https://www.tmxmoney.com/en/csuite.html.
About Satellos Bioscience Inc.
(TSXV: MSCL)
Satellos is a biotechnology company dedicated to developing
lifechanging medicines to treat degenerative muscle conditions.
CNW sponsored announcement. To learn more visit
www.newswire.ca.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/tsx-venture-exchange-satellos-bioscience-inc-view-from-the-c-suite-301905913.html
SOURCE TSX Venture Exchange
Copyright 2023 Canada NewsWire
Satellos Bioscience (TSXV:MSCL)
過去 株価チャート
から 4 2024 まで 5 2024
Satellos Bioscience (TSXV:MSCL)
過去 株価チャート
から 5 2023 まで 5 2024